Pharmaceutical Excipient Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI4173
Pharmaceutical Excipient Market size is projected to experience immense growth from 2019 to 2025.
Growing demand of medicines due to increasing patients will result in rapid growth of pharmaceutical excipient business over the projected period. Additionally, pharmaceutical excipients are incorporated in formulation to achieve longer shelf-life, that will boost the demand of pharmaceutical excipients market growth. Growing rate of chronic and lifestyle disease such as obesity and diabetes will foster the demand of medicines that will positively influence pharmaceutical excipient market growth in the forthcoming years.
Rising demand of pharmaceutical excipients in emerging market for generic medicine formulation will result into rapid growth of pharmaceutical excipient business. In emerging markets such as Asia Pacific and East Africa demand for pharmaceutical excipient is growing. The reason behind growing demand is bulk requirement of cost-effective excipients by local manufacturers, that may accelerate growth of pharmaceutical excipient market.
Strict regulations and mandates associated with pharmaceutical excipient manufacturing site will act as a restraint for pharmaceutical excipient market in forthcoming years. Moreover, lack of separate guidelines for novel excipients will negatively affect pharmaceutical excipients business growth in the future.
Binder excipient segment will foresee significant growth across the forecast timeframe. High growth is attributed to necessity of binders in pharmaceutical formulations. Wide array of applications of binders in various formulation will be the major growth rendering factor. Apart from solid dosage forms, binders are also used in various liquid and semi solid dosage formulation such as emulsion, creams and lotions. Thus, binder segment is expected to grow significantly over projected years.
Solid dosage formulation segment will show rapid growth in the future. High growth is attributed to various advantages associated with solid dosage formulation that include cost-effectiveness, accuracy and stable dosage form. Solid dosage formulations are easy to handle and transport. Additionally, solid dosage formulation is more preferred by patients to avoid parenterals, thereby leading to higher demand of solid dosage formulation.
Pharmaceutical companies segment will foresee significant growth in the forthcoming years. Pharmaceutical companies are engaged in mass production of medicines that require large volumes of excipients. Moreover, pharmaceutical companies tend to purchase excipients in bulk thus increasing rate of export and import of pharmaceutical excipients. Aforementioned factors will lead to growth of pharmaceutical companies segment.
U.S. pharmaceutical excipient market is expected to show significant growth over projected years. U.S. is leader of pharmaceutical market with mass production of medicines. According to International Trade Organization 2015 statistics, biopharmaceutical business accounted USD 1.3 trillion which significantly increases demand of excipients that may lead to high growth of pharmaceutical excipients market growth.
Indian pharmaceutical excipient market will foresee rapid growth in upcoming year’s due to high demand of generic medicines. According to India Brand Equity Foundation 2017 statistic, Indian pharmaceutical market is forecasted to grow at 30% to reach USD 100 billion by 2025. High growth of pharmaceutical market will significantly drive the Indian pharmaceutical excipient market across the forecast timeframe.
Some of the major market players involved in pharmaceutical excipient market include Fuji Chemical Industry Co Ltd, Ashland, Inc., Azelis Pharm, Avantor Performance Materials, Basf Se, DFE Pharm, Euro Life Healthcare Pvt Ltd, Finar Chemicals Limited, Evonik Industries Ag and FMC Corporation. For instance, in March 2019, Azelis Pharm announced successful acquisition of Chemroy Canada, Inc. a Canadian pharmaceutical excipient manufacturer. This will enable the company to expand its presence in Canadian market and generate more revenues.
Pharmaceutical Excipient Market by Excipient Type, 2014-2025 (USD Million)
- Suspending agent & viscosity modifier
- Flavoring agent
- Chelating agent
Pharmaceutical Excipient Market by Formulation Type, 2014-2025 (USD Million)
- Solid dosage formulation
- Liquid dosage formulation
- Semi-solid dosage formulation
Pharmaceutical Excipient Market by End-use, 2014-2025 (USD Million)
- Pharmaceutical companies
- Research institutes
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- Ashland, Inc.
- Avantor Performance Materials
- Azelis Pharma
- Basf Se
- DFE Pharma
- Euro Life Healthcare Pvt Ltd
- Evonik Industries Ag
- Finar Chemicals Limited
- FMC Corporation
- Fuji Chemical Industry Co Ltd
- Huber Engineered Materials
- Ingredion Incorporated
- JRS Pharma
- Kirsch Pharma
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.